Women do get ALS, but at lower rates than men

Yes, women develop ALS, but the disease strikes men roughly 1.5 times more often than women. This difference appears across all age groups and all populations studied so far. The reason for this male predominance remains unknown — researchers have not identified a genetic or biological mechanism that fully explains it, though several theories exist.

When women do develop ALS, the disease itself behaves somewhat differently. Women tend to be diagnosed at a slightly older age than men, and some studies suggest women may have a slower disease progression, though this varies widely from person to person. The underlying cause of ALS — whether inherited or sporadic — does not appear to differ between sexes in any consistent way.

Key Takeaways

  • ALS occurs in both men and women, but men account for roughly 60 percent of cases and women for roughly 40 percent.
  • Women are typically diagnosed with ALS at an older average age than men, though individual cases vary widely.
  • Some research suggests women may experience slower disease progression than men, but this pattern is not universal and does not hold for every person.
  • Inherited ALS (familial ALS) and sporadic ALS occur in both sexes at similar rates relative to their overall ALS incidence.

Why the male predominance exists remains unclear

The fact that more men than women develop ALS has been documented for decades, but the cause is not well understood. Researchers have proposed several explanations. One theory involves sex hormones — estrogen in women may have a protective effect against motor neuron damage, though this has not been proven in humans. Another focuses on genetic differences in how men and women repair damaged DNA or handle cellular stress.

A third possibility is that the disease presents differently in women and goes undiagnosed longer, meaning the true rate might be closer to equal but women are simply identified later. This theory remains speculative. The most honest answer is that neuroscientists do not yet know why ALS shows this sex difference, and the answer likely involves multiple biological pathways rather than a single cause.

Diagnosis and symptoms appear similar across sexes

The early signs of ALS — muscle weakness, twitching, stiffness, or slurred speech — do not differ meaningfully between men and women. A woman with ALS may first notice weakness in her hands, legs, or voice, just as a man would. The diagnostic process is the same: neurological examination, electromyography (EMG), and sometimes imaging or genetic testing.

One practical difference is that women may face longer diagnostic delays simply because ALS is less common in women, and a doctor seeing a woman with progressive weakness might consider other diagnoses first. This is not a biological difference but a statistical one — when a condition is rarer in a group, it takes longer to recognize. Bringing a detailed symptom timeline to appointments can help shorten this delay.

Disease progression may differ, but individual variation is large

Several studies have found that women with ALS progress more slowly on average than men — meaning the time from symptom onset to loss of walking ability, or to needing a ventilator, tends to be longer in women. However, this is an average across many people, and individual cases vary enormously. Some women progress very rapidly; some men progress very slowly. A woman's prognosis cannot be predicted from her sex alone.

The reasons for any sex-based difference in progression are not clear. Hormonal factors, differences in muscle physiology, or variations in how the immune system responds to motor neuron damage have all been suggested. What matters clinically is that your own disease course depends on many factors — the specific form of ALS you have, your age at onset, your overall health, and genetic variations unique to you — not on your sex.

Caregiving and social factors affect women differently

While the biology of ALS does not differ dramatically between sexes, the lived experience often does. Women with ALS are more likely to be primary caregivers for children or aging parents before their diagnosis, which can complicate their own care planning. Women may also face different social expectations around independence and asking for help, which can delay them from seeking support services.

Additionally, women make up the majority of ALS caregivers — spouses, adult children, and paid care workers are more often women — which means women bear a disproportionate burden in the ALS community overall. Support groups and care planning resources that acknowledge these gender-specific challenges can be valuable for both women with ALS and the women caring for them.

Inherited ALS occurs in women at similar rates to men

If ALS runs in your family, your risk does not depend on your sex. Familial ALS (fALS) — the inherited form, usually caused by mutations in genes like SOD1, C9orf72, or FUS — affects men and women equally when the mutation is present. A woman who carries a disease-causing mutation has roughly the same chance of developing ALS as a man who carries the same mutation, though age of onset and severity can still vary.

If you have a family history of ALS, genetic counseling can help you understand your own risk and the implications for your children. Genetic testing is available and may be recommended if multiple family members have been diagnosed. The results apply equally regardless of your sex.

Frequently Asked Questions

Can women pass ALS to their children?

If a woman has inherited ALS caused by a genetic mutation, she can pass that mutation to her children — sons and daughters equally. Each child of an affected parent has roughly a 50 percent chance of inheriting the mutation. Not everyone who inherits the mutation develops ALS, and age of onset varies. Genetic counseling before or during pregnancy can help you understand these risks.

Does pregnancy affect ALS or does ALS affect pregnancy?

ALS diagnosed before pregnancy does not prevent pregnancy, but it can complicate it. Progressive weakness may make pregnancy physically demanding, and some ALS medications are not recommended during pregnancy. Women with ALS who want to become pregnant should discuss timing and medication adjustments with both their neurologist and obstetrician before conception.

Are there ALS treatments that work differently in women?

The approved ALS medications — riluzole, edaravone, and others — have been tested in both men and women and work through the same biological mechanisms in both sexes. No treatment has been shown to work better in one sex than the other. Individual response to any medication varies by person, not by sex.

Why do I hear more about men with ALS?

Because more men develop ALS overall, men make up a larger share of ALS cases, clinical trials, and public awareness campaigns. This can create the false impression that ALS is primarily a male disease. Women with ALS are equally affected by the disease and equally deserving of research attention and support resources.